000 | 01097 a2200325 4500 | ||
---|---|---|---|
005 | 20250516032144.0 | ||
264 | 0 | _c20110815 | |
008 | 201108s 0 0 eng d | ||
022 | _a1750-7448 | ||
024 | 7 |
_a10.2217/imt.11.12 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaleem, Benazir | |
245 | 0 | 0 |
_aRemission in inflammatory arthritis: a new immunological target. _h[electronic resource] |
260 |
_bImmunotherapy _cApr 2011 |
||
300 |
_a459-63 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 |
_aRemission Induction _xmethods |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aWalsh, Ceara A E | |
700 | 1 | _aEmery, Paul | |
773 | 0 |
_tImmunotherapy _gvol. 3 _gno. 4 _gp. 459-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/imt.11.12 _zAvailable from publisher's website |
999 |
_c20731319 _d20731319 |